AC
AYTU icon

Armistice Capital’s AYTU BioPharma AYTU Stock Holding History

Armistice Capital’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-57,597
Closed -$69.1K – 209
2025
Q1 		$69.1K Sell
57,597
-92,403
-62% -$134K ﹤0.01% 208
2024
Q4 		$255K Sell
150,000
-86,000
-36% -$157K ﹤0.01% 190
2024
Q3 		$555K Sell
236,000
-16,000
-6% -$41.4K 0.01% 188
2024
Q2 		$736K Buy
+252,000
New +$761K 0.01% 167
2022
Q2 		– Sell
-118,997
Closed -$2.57M – 181
2022
Q1 		$2.57M Buy
+118,997
New +$2.96M 0.05% 95
2021
Q3 		– Sell
-67,119
Closed -$6.72M – 138
2021
Q2 		$6.72M Hold
67,119
– – 0.12% 92
2021
Q1 		$10.2M Buy
67,119
+452
+0.7% +$71.8K 0.23% 76
2020
Q4 		$7.97M Buy
+66,667
New +$12.1M 0.27% 72
2020
Q1 		– Sell
-39,750
Closed -$7.73M – 81
2019
Q4 		$7.73M Buy
39,750
+14,150
+55% +$2.72M 0.45% 55
2019
Q3 		$6.2M Buy
25,600
+15,600
+156% +$4.7M 0.41% 50
2019
Q2 		$3.78M Hold
10,000
– – 0.24% 51
2019
Q1 		$3.34M Buy
10,000
+9,500
+1,900% +$2.37M 0.18% 60
2018
Q4 		$79K Buy
+500
New +$110K 0.01% 69
2018
Q2 		– Sell
-375
Closed -$956K – 77
2018
Q1 		$956K Buy
375
+283
+308% +$1.95M 0.07% 61
2017
Q4 		$818K Buy
+92
New +$1.1M 0.08% 63

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $413M AUM 109.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital's AYTU Position: Q2 2025 in Review

Armistice Capital sold out of AYTU BioPharma (AYTU) in Q2 2025, closing a stake of 57,597 shares — an estimated $69.1K sold.

Armistice Capital first reported a position in AYTU in Q4 2017 and held it in 15 quarters. The position peaked at $10.2M in Q1 2021. 32 funds tracked by Wall St. Rank hold AYTU as of Q2 2025.

  • Armistice Capital reported no remaining AYTU BioPharma position as of Q2 2025 after selling out during the quarter.
  • Armistice Capital sold 57,597 AYTU BioPharma shares in Q2 2025, an estimated $69.1K.
  • Armistice Capital first reported a position in AYTU BioPharma in Q4 2017 and held it in 15 quarters.
  • Armistice Capital's AYTU BioPharma position peaked at $10.2M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2025.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.